Sarah Jane Maidens Portfolio
Invests via Camrose Capital Investment Partners LLP | Managed by Sarah Jane Maidens, Christopher Patrick Hickey, Edward Charles Molson, Yavuz Arikan
Invests via Camrose Capital Investment Partners LLP
Managed by Sarah Jane Maidens, Christopher Patrick Hickey, Edward Charles Molson, Yavuz Arikan
Automatically Tracked
Deploys growth capital into software and healthcare services across Europe and North America, prioritizing scalable business models and revenue efficiency. Sarah Jane Maidens is an investor and former operating executive who blends corporate development experience with hands-on portfolio oversight, sourcing cross-border deals, driving commercial acceleration and selective M&A. Frequently serves on boards and advises management teams on governance, go-to-market strategy and capital structure optimization.
Deploys growth capital into software and healthcare services across Europe and North America, prioritizing scalable business models and revenue efficiency. Sarah Jane Maidens is an investor and former operating executive who blends corporate development experience with hands-on portfolio oversight, sourcing cross-border deals, driving commercial acceleration and selective M&A. Frequently serves on boards and advises management teams on governance, go-to-market strategy and capital structure optimization.
Investment Philosophy & Strategy
Focuses on growth-stage software and healthcare services across Europe and North America, prioritizing scalable, revenue-efficient business models and durable unit economics. Combines corporate-development rigor with hands-on portfolio stewardship, sourcing cross-border opportunities, accelerating commercial motion, and executing selective M&A to create scale. Prefers active board-level engagement to optimize governance, go-to-market and capital structure. Targets multi-year, value-oriented growth with disciplined downside protection through staged capital, performance-linked milestones and operational KPIs.
Focuses on growth-stage software and healthcare services across Europe and North America, prioritizing scalable, revenue-efficient business models and durable unit economics. Combines corporate-development rigor with hands-on portfolio stewardship, sourcing cross-border opportunities, accelerating commercial motion, and executing selective M&A to create scale. Prefers active board-level engagement to optimize governance, go-to-market and capital structure. Targets multi-year, value-oriented growth with disciplined downside protection through staged capital, performance-linked milestones and operational KPIs.
Disclaimer: This Portfolio is derived from and computed based on publicly available data from SEC filings.
Gain and growth charts are calculated per selected timeframe:
19.44%
Gain -0.04%
Monthly
0.96%
Yearly
12.16%
Drawdown
26.18%
$835M
Equity
Holdings
$835M
Investment
$789.43M
$45.86M
Profit -$100,947.92
Realized
$294,128.02
Unrealized
$45.57M
Dividends
$7.12M
Goals
Avg. 100% completed goals
Yearly
Gain > 5% 2026
Yearly
Gain < 20% 2026
Today
Compared To Yesterday
Gain
-0.04%
Profit
-$100,947.92
Win %
47%
This Week
Compared To Last Week
Gain
-0.01%
Profit
-$100,947.92
Win %
47%
This Month
Compared to last month
Gain
1.63%
Profit
$13.41M
Win %
47%
This Year
Compared to last year
Gain
9.27%
Profit
$70.8M
Win %
47%
EXPD Expeditors International of Washington, Inc.
+0.46%
+$373,775.39 
YUM Yum! Brands, Inc.
-2.75%
-$1.88M 
MLM Martin Marietta Materials, Inc.
-2.49%
-$1.96M 
TXN Texas Instruments Inc
-2.47%
-$3.25M 
MA Mastercard Incorporated
-1.44%
-$1.43M 
SPGI S&P Global Inc.
-1.43%
-$1.38M 
CNM Core & Main Inc.
-1.18%
-$1.22M 
HLT Hilton Worldwide Holdings Inc.
-0.58%
-$569,497.12 
ADP Automatic Data Processing Inc.
-0.5%
-$234,314.31 
ROP Roper Technologies Inc.
-0.29%
-$126,906.05 Events
Loading...
Dividends
Dividend Analysis
Loading...
No Data
| Trades 56 | Longs Won 27/56 48% | Profit Factor 1.83 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $3.97M |
| Average Win $3.74M | Best Trade (Jul 19) $12.8M | Sharpe Ratio 0 |
| Average Loss -$1.9M | Worst Trade (Jul 19) -$9.49M | Z-Score -0.4 (30.75%) |
| Commissions $0 | Avg. Trade Length 11m | Expectancy $818,996.99 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | 0.01% |
| Consecutive Losing Trades | 440 | 396 | 352 | 308 | 264 | 220 | 176 | 132 | 88 | 44 |
Hover over the desired column for a detailed explanation.
Returns
Overall, MonthlyNo Data
Option values are updated at end of day.
No Data
No Data
Option values are updated at end of day.
No Data
No Data
No Data
No Data
